MLICM
INZY

Metropolitan Life Insurance Company (MetLife)’s Inozyme Pharma INZY Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,728
Closed -$20.9K – 1046
2024
Q1 		$20.9K Sell
2,728
-147
-5% -$1.13K ﹤0.01% 1840
2023
Q4 		$12.2K Buy
2,875
+1,006
+54% +$4.29K ﹤0.01% 2112
2023
Q3 		$7.85K Hold
1,869
– – ﹤0.01% 2319
2023
Q2 		$10.4K Buy
+1,869
New +$10.4K ﹤0.01% 2282